A new study from Sweden revealed that screening men between 50 and 65 years old with the PSA test for prostate cancer reduced deaths by nearly a half over 14 years and concluded that prostate cancer screening compares favorably with screening for other cancers, but also cautioned that the risk of overdiagnosis is substantial, causing an expert to point out that such findings should not be taken as a reason to introduce universal PSA testing...
More...
More...